Forensic · CGON

CG Oncology

4
LOW
4/100
1 signal from 2 red flags, 0 cyber, 0 dilution events

Top signals

Officer Departure Recent
C-suite officer departure (Item 5.02) in the last 6 months.
+4

Bear case preview · free

CGON presents a low red-flag profile overall, with the primary concern being a recent C-suite officer departure disclosed in Item 5.02 within the last six months. While a single departure doesn't necessarily indicate operational distress, it warrants monitoring for potential context around strategic disagreements, execution challenges, or stability issues that may not yet be reflected in public filings. Watch for additional officer changes, guidance revisions, or clarifications on the departure rationale in the next 30-90 days to assess whether this represents isolated turnover or a symptom of deeper organizational concerns.

↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.

What we checked

✓ Red flags · 36mo
2 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9 · one-time · emailed in under a minute

The full bear case on CGON

Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.

No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.

Not ready to buy? Get a free preview by email instead

We'll email you the top 3 signals on CGON + a discount code for the full report. No subscription, no spam.

Share this score: X / Twitter

Score another ticker

Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.